Overview
Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome (also known as Beare-Stevenson cutis gyrata syndrome) is an extremely rare genetic disorder characterized by the triad of cutis gyrata (furrowed, thickened skin with a corrugated appearance), acanthosis nigricans (dark, velvety thickening of the skin, particularly in body folds), and craniosynostosis (premature fusion of the skull bones). The condition is caused by gain-of-function mutations in the FGFR2 (fibroblast growth factor receptor 2) gene. Affected individuals typically present at birth with a distinctive craniofacial appearance including a cloverleaf skull deformity (Kleeblattschädel) or other forms of craniosynostosis, midface hypoplasia, prominent eyes, and ear anomalies. The widespread skin abnormalities, particularly the deeply furrowed cutis gyrata pattern, are a hallmark feature that distinguishes this condition from other FGFR2-related craniosynostosis syndromes. The syndrome affects multiple body systems, including the skeletal system (craniosynostosis, digital anomalies), the integumentary system (cutis gyrata, acanthosis nigricans, skin tags), and the craniofacial structures. Additional features may include anogenital anomalies, a prominent umbilical stump, and developmental delay. The prognosis is generally poor, with many affected individuals experiencing significant morbidity and early mortality, often related to respiratory complications or neurological compromise from increased intracranial pressure. Management is supportive and multidisciplinary, involving neurosurgical intervention for craniosynostosis to relieve intracranial pressure, craniofacial reconstruction, and dermatologic care. There is no cure for the underlying genetic condition, and treatment focuses on addressing individual symptoms and complications as they arise.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome.
Community
No community posts yet. Be the first to share your experience with Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome.
Start the conversation →Latest news about Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome
No recent news articles for Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome
What is Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome?
Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome (also known as Beare-Stevenson cutis gyrata syndrome) is an extremely rare genetic disorder characterized by the triad of cutis gyrata (furrowed, thickened skin with a corrugated appearance), acanthosis nigricans (dark, velvety thickening of the skin, particularly in body folds), and craniosynostosis (premature fusion of the skull bones). The condition is caused by gain-of-function mutations in the FGFR2 (fibroblast growth factor receptor 2) gene. Affected individuals typically present at birth with a distinctive craniofacial appearan
How is Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome inherited?
Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome typically begin?
Typical onset of Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome is neonatal. Age of onset can vary across affected individuals.